Related Experiment Videos

Lessons learned from young-onset diabetes in China

Juliana C N Chan1, Maggie C Y Ng

  • 1Department of Medicine and Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, 30-32 Ngan Shing Street, Shatin, Hong Kong, China. jchan@cuhk.edu.hk

Current Diabetes Reports
|May 6, 2003
PubMed

Insights

The rising prevalence of young-onset diabetes in China presents diagnostic and therapeutic challenges. Early identification and tailored management are crucial for these heterogeneous cases.

Area of Science:

  • Endocrinology and Metabolism
  • Genetics and Molecular Biology
  • Public Health

Background:

  • Young-onset diabetes (YOD) prevalence is increasing in China.
  • YOD is etiologically and phenotypically diverse, complicating diagnosis and treatment.
  • A significant portion of YOD patients experience insulin secretory failure due to autoimmune, monogenic, or unidentified causes.

Purpose of the Study:

  • To highlight the diagnostic and therapeutic challenges posed by the rising prevalence of YOD in China.
  • To emphasize the need for a multidisciplinary and holistic approach in managing YOD.
  • To underscore the potential of understanding the molecular basis of YOD for improved clinical outcomes.

Main Methods:

  • Review of current literature on YOD in China.
  • Analysis of etiological and phenotypic heterogeneity in YOD.
  • Discussion of diagnostic and management strategies for YOD.

Main Results:

  • YOD exhibits significant heterogeneity, with 30-50% presenting insulin secretory failure.
  • Other YOD cases show a family history and metabolic syndrome features.
  • Current management requires specialized, integrated care approaches.

Conclusions:

  • Effective management of YOD necessitates early identification and tailored interventions.
  • A deeper understanding of the molecular underpinnings of YOD is essential for advancing diagnosis, classification, and treatment.
  • Multidisciplinary collaboration is key to addressing the complexities of YOD.

Related Concept Videos

Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...